Scientist, Analytical Operations
Gilead Sciences
Summary
The Scientist, Analytical Ops provides analytical and scientific leadership to support the development, characterization, and advancement of drug candidates. Working across analytical disciplines and functions, this role plans and executes laboratory activities, develops fit-for-purpose analytical methods, and interprets scientific data to address complex development challenges.
Job description
Key Responsibilities
- Provide technical leadership in the development and optimization of analytical methods for complex or challenging assignments.
- Define analytical strategies, approaches, and techniques that address technical needs and advance project objectives.
- Design, plan, and execute laboratory experiments to resolve complex analytical and development challenges.
- Maintain a strong hands-on laboratory presence and apply scientific judgment to troubleshoot experiments, interpret data, and resolve technical issues.
- Anticipate analytical needs across the drug development process and proactively address evolving project requirements.
- Plan, prioritize, and execute analytical activities for raw materials, intermediates, drug substances, and drug products in alignment with project objectives and development timelines.
- Design and perform physicochemical analyses, including liquid chromatography, gas chromatography, and Karl Fischer analysis.
- Conduct fit-for-purpose development studies, including stress and degradation studies and accelerated stability approaches.
- Develop and apply sensitive analytical methods to assess process-related impurities, mutagenic and potentially mutagenic impurities, and nitrosamines.
- Contribute to scientifically sound impurity control strategies based on analytical findings and development needs.
- Provide analytical expertise to support the development and characterization of formulations, product intermediates, and dosage forms, including solid oral, parenteral, and combination products.
- Apply Quality by Design principles, including Design of Experiments and Method Operable Design Region approaches, consistent with ICH Q14 principles.
- Maintain current knowledge of scientific literature, emerging analytical technologies, and relevant regulatory expectations.
- Lead critical components of cross-functional projects and contribute to departmental initiatives or technology programs.
- Collaborate across functions to solve complex scientific and technical problems and provide analytical recommendations.
Basic Qualifications
- Bachelor's Degree and 6+ years of relevant experience OR Master's Degree and 4+ years of relevant experience OR PhD or PharmD and 0+ years of relevant experience
Preferred Qualifications
- Degree in chemistry, biology, or a related scientific discipline.
- Pharmaceutical or biotechnology industry experience.
- Strong hands-on experience in analytical method development, optimization, and troubleshooting.
- Experience with liquid chromatography, gas chromatography, Karl Fischer analysis, or related analytical techniques.
- Experience conducting stability, stress, and degradation studies.
- Knowledge of impurity assessment and control, including process-related impurities, mutagenic and potentially mutagenic impurities, and nitrosamines.
- Experience applying Quality by Design, Design of Experiments, or Method Operable Design Region principles.
- Experience supporting the development and characterization of solid oral, parenteral, or combination products.
- Ability to independently define analytical approaches and address complex laboratory and development challenges.
- Strong scientific judgment and data interpretation skills.
- Ability to collaborate effectively across analytical disciplines, functions, and organizational levels.
- Ability to begin contributing to hands-on laboratory activities with limited onboarding.
Requirements
- Bachelor's Degree and 6+ years of relevant experience OR Master's Degree and 4+ years of relevant experience OR PhD or PharmD and 0+ years of relevant experience
- Degree in chemistry, biology, or a related scientific discipline
- Pharmaceutical or biotechnology industry experience
- Strong hands-on experience in analytical method development, optimization, and troubleshooting
- Experience with liquid chromatography, gas chromatography, Karl Fischer analysis, or related analytical techniques
- Experience conducting stability, stress, and degradation studies
- Knowledge of impurity assessment and control, including process-related impurities, mutagenic and potentially mutagenic impurities, and nitrosamines
- Experience applying Quality by Design, Design of Experiments, or Method Operable Design Region principles
- Experience supporting the development and characterization of solid oral, parenteral, or combination products
- Ability to independently define analytical approaches and address complex laboratory and development challenges
- Strong scientific judgment and data interpretation skills
- Ability to collaborate effectively across analytical disciplines, functions, and organizational levels
- Ability to begin contributing to hands-on laboratory activities with limited onboarding
Benefits
- Medical, Dental & Vision
- Life Insurance
- Paid Time Off
- Annual Bonus
- Stock-Based Long-Term Incentives
Company overview
Gilead Sciences, Inc. is a leading American biopharmaceutical company headquartered in Foster City, California, that specializes in researching, developing, and commercializing innovative medicines for life-threatening diseases. Founded in 1987, Gilead has grown into a global healthcare leader with approximately 17,600 employees worldwide. The company's primary therapeutic focus areas include HIV/AIDS, viral hepatitis (hepatitis B and C), oncology, inflammation, and respiratory diseases. Gilead is renowned for its groundbreaking antiviral therapies, including Sovaldi and Harvoni for hepatitis C, and its comprehensive portfolio of HIV treatments such as Truvada, Atripla, and Biktarvy. The company also developed Veklury (remdesivir) for COVID-19 treatment. Gilead operates as a publicly traded company on the NASDAQ (GILD) and is a component of both the Nasdaq-100 and S&P 100 indices. Through strategic acquisitions like Kite Pharma and Immunomedics, Gilead has expanded into cell therapy and oncology, demonstrating its commitment to advancing medical science and improving patient outcomes globally.